scholarly article | Q13442814 |
P356 | DOI | 10.1097/00000658-198411000-00009 |
P698 | PubMed publication ID | 6385881 |
P2093 | author name string | R L Kirkman | |
C B Carpenter | |||
T B Strom | |||
N L Tilney | |||
E L Milford | |||
J L Araujo | |||
P2860 | cites work | Cyclosporin A in cadaveric organ transplantation | Q34778331 |
Cadaveric renal transplantation under cyclosporine-steroid therapy | Q37310997 | ||
Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids | Q37311411 | ||
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
Factors Contributing to the Declining Mortality Rate in Renal Transplantation | Q39630254 | ||
Effects of the new anti-lymphocytic peptide cyclosporin A in animals | Q40788620 | ||
The effect of cyclosporine on early graft function in human renal transplantation | Q42247492 | ||
Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity | Q44162251 | ||
A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months | Q70161611 | ||
Improving Success Rates of Kidney Transplantation | Q70270799 | ||
Cyclosporin a used alone or in combination with low-dose steroids in cadaveric renal transplantation | Q70302607 | ||
Cyclosporine: Five Years' Experience in Cadaveric Renal Transplantation | Q70309967 | ||
Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation | Q70559248 | ||
Cyclosporin A | Q70565131 | ||
A Radioimmunoassay to Measure Cyclosporin a in Plasma and Serum Samples | Q70946075 | ||
The diagnosis of testicular torsion | Q71712309 | ||
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody | Q72721372 | ||
Cyclosporin A in renal transplantation: a prospective randomized trial | Q72938314 | ||
Kidney Transplantation in Modified Recipients | Q79028831 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 605-613 | |
P577 | publication date | 1984-11-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | Experience with cyclosporine and steroids in clinical renal transplantation | |
P478 | volume | 200 |
Q42225955 | Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital |
Q39699974 | Cyclosporine conversion |
Q94359946 | Cyclosporine nephrotoxicity |
Q37246076 | Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010. |
Q45252813 | Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways |
Q45402070 | Effect of cyclosporin A on T cell immunity. II. Defective thymic education of CD4 T helper cell function in cyclosporin A-treated mice |
Q44862290 | Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis |
Q38015284 | Principles of immunosuppression. |
Q44299188 | Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients |
Q69924233 | Small bowel transplantation |
Q70321929 | Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin |
Q43641907 | Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts |
Q54398086 | The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. |
Q41201521 | The use of therapeutic drug monitoring to optimise immunosuppressive therapy |
Q35600377 | Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats |
Q39699978 | Use of living donors in renal transplantation. |
Search more.